LENZKEN, SILVIA CAROLINA
 Distribuzione geografica
Continente #
EU - Europa 172
NA - Nord America 168
AS - Asia 118
SA - Sud America 4
OC - Oceania 1
Totale 463
Nazione #
US - Stati Uniti d'America 168
CN - Cina 117
IE - Irlanda 59
UA - Ucraina 38
DE - Germania 22
FI - Finlandia 22
IT - Italia 18
GB - Regno Unito 7
FR - Francia 6
BR - Brasile 4
JP - Giappone 1
NZ - Nuova Zelanda 1
Totale 463
Città #
Dublin 59
Chandler 45
Jacksonville 42
Nanjing 33
Beijing 21
Nanchang 17
Princeton 10
Rodano 10
Ashburn 9
Hebei 9
Lawrence 8
Shanghai 8
Shenyang 7
Boardman 6
Changsha 6
Helsinki 6
Medford 6
Tianjin 6
Wilmington 5
Jiaxing 4
Sao Joao da Boa Vista 4
Milan 3
Jinan 2
Auckland 1
Changchun 1
Dearborn 1
Des Moines 1
Hangzhou 1
London 1
Los Angeles 1
Munich 1
Ningbo 1
Norwalk 1
Pavia 1
Seattle 1
Woodbridge 1
Totale 339
Nome #
A novel pathway based on the recruitment of casein kinase 2 is involved in APP processing following cholinergic stimulation. 71
Nicotinic component of galantamine in the regulation of amyloid precursor protein processing 67
Role of b-amyloid in the pathophysiology of Alzheimer’s disease and cholinesterase inhibition: facing the biological complexity to treat the disease. 63
COGNITION ENHANCERS BETWEEN TREATING AND DOPING THE MIND 62
APP processing: some details of downstream cholinergic stimulation. 59
The Search For Disease Modifying Drugs For Neurodegenerative Disorders 52
Galantamina: il farmaco e il contesto 50
Development of the first Gateway firefly luciferase vector and use of reverse transcriptase in FLOE (Fluorescently Labeled Oligonucleotide Extension) reactions. 44
Totale 468
Categoria #
all - tutte 1.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020133 32 50 0 7 0 7 1 8 0 19 9 0
2020/202148 7 6 0 7 0 7 0 7 0 7 7 0
2021/202225 0 0 0 0 0 0 0 3 0 0 4 18
2022/2023140 13 15 0 8 16 13 0 5 64 1 5 0
2023/202442 7 5 0 3 5 7 0 5 1 6 2 1
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 468